| Amber West, PHARMD | |
|
300 Twining St Bldg 760, Montgomery, AL 36112-6027 | |
| (334) 953-5143 | |
| Not Available |
| Full Name | Amber West |
|---|---|
| Gender | Female |
| Speciality | Pharmacist |
| Location | 300 Twining St Bldg 760, Montgomery, Alabama |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1790288900 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 183500000X | Pharmacist | 18966 (Alabama) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Amber West, PHARMD 160 Stone Park Blvd Apt 109, Pike Road, AL 36064-2993 Ph: () - | Amber West, PHARMD 300 Twining St Bldg 760, Montgomery, AL 36112-6027 Ph: (334) 953-5143 |
News Archive
Trigemina, Inc., a biopharmaceutical company focused on the discovery and development of non-narcotic, nasally delivered, analgesic drug products, today announced that the Instituto de Salud Publica of Chile has approved the Company's protocol for its Phase 2 clinical study of TI-001, intranasal oxytocin, for the treatment of chronic migraine.
A new study published in the journal Nature shows that there are literally hundreds of viruses large enough to consume bacteria, and with properties that are typical of a living organism rather than the non-living self-replicating packages of DNA/RNA that viruses are often assumed to be.
SDI and Cegedim Strategic Data (CSD) announced today that they will jointly launch a new market research service that tracks selling activities in the oncology therapeutic market. The Oncology Selling Audit will be released in January 2011; 2 years of history will be available for reporting and analysis.
AVEO Pharmaceuticals, Inc., a biopharmaceutical company focused on discovering, developing and commercializing cancer therapeutics, today announced that it has initiated a Phase 2 clinical trial evaluating SCH 900105 (also referred to as AV-299) for the treatment of non-small cell lung cancer. The initiation of this trial triggers an $8.5 million milestone payment by Merck to AVEO resulting from a 2007 agreement between AVEO and Schering-Plough (now Merck).
A federal appeals court Tuesday lambasted the Department of Veterans Affairs for failing to care for those suffering post-traumatic stress disorder and ordered a major overhaul of the behemoth agency. Treatment delays for PTSD and other combat-related mental illnesses are so "egregious" that they violate veterans' constitutional rights and contribute to the despair behind many of the 6,500 suicides among veterans each year, the U.S. 9th Circuit Court of Appeals said in its 2-1 ruling.
› Verified 7 days ago
Dr. James D Wurst, PHARM.D. Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1725 Pine St, Montgomery, AL 36106 Phone: 334-293-8696 | |
Mr. Steven Matthew Atchison, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 5331 Perimeter Pkwy, Montgomery, AL 36116 Phone: 334-356-8389 | |
Dr. Tajah Jones, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 2520 Fairlane Dr Ste 300, Montgomery, AL 36116 Phone: 334-356-7627 | |
Jason Paul Rome, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 355 Industrial Park Blvd, Montgomery, AL 36117 Phone: 800-278-1777 | |
Dr. James Miracle, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 2015 Normandie Dr, Montgomery, AL 36111 Phone: 334-750-1528 | |
Mr. Robert N Holden, R.PH. Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 8601 Carillion Pl, Montgomery, AL 36117 Phone: 334-270-1855 | |
Kurt Hetler, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 3881 Atlanta Hwy, Montgomery, AL 36109 Phone: 334-271-5174 Fax: 334-271-5724 |